Glycoprotein IIb/IIIa Inhibitors May Modulate the Clinical Benefit of Radial Access as Compared to Femoral Access in Primary Percutaneous Coronary Intervention: A Meta-Regression and Meta-Analysis of Randomized Trials

Glycoprotein IIb/IIIa Inhibitors May Modulate the Clinical Benefit of Radial Access as Compared to Femoral Access in Primary Percutaneous Coronary Intervention: A Meta-Regression and Meta-Analysis of Randomized Trials

Objectives. Several randomized controlled trials (RCTs) consistently reported better clinical outcomes with radial as compared to femoral access for primary percutaneous coronary intervention (PCI). Nevertheless, heterogeneous use of potent antiplatelet drugs, such as Gp IIb/IIIa inhibitors (GPI), a...

Full description

Bibliographic Details
Main Authors:	Stefano Rigattieri, Ernesto Cristiano, Francesca Giovannelli, Antonella Tommasino, Francesco Cava, Barbara Citoni, Domenico Maria Zardi, Andrea Berni, Massimo Volpe
Format:	Article
Language:	English
Published:	Hindawi-Wiley 2021-01-01
Series:	Journal of Interventional Cardiology
Online Access:	http://dx.doi.org/10.1155/2021/9917407

Similar Items

Safety of Glycoprotein IIb-IIIa Inhibitors Used in Stroke-Related Treatment: A Systematic Review and Meta-Analysis
by: Xiaolin Zhu MD, et al.
Published: (2020-07-01)

Glycoprotein IIb/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression
by: Carolina Saleiro, et al.
Published: (2020-11-01)

Inibidores da glicoproteína IIb/IIIa na prática clínica Inhibidores de la glicoproteína IIb/IIIa en la práctica clínica Glycoprotein IIb/IIIa inhibitors in clinical practice
by: Felipe Maia, et al.
Published: (2009-01-01)

The antiaggregative mechanism of pyridoxal -5''- phosphate (PLP) on the glycoprotein IIb-IIIa( GPIIb-IIIa) and morphology of platelets
by: Wen - Jen Yu, et al.
Published: (1995)

The blocking effect of the glycoprotein IIb/IIIa receptor in the mouse model of asthma
by: Seo-Hee Kim, et al.
Published: (2021-07-01)

Glycoprotein IIb-IIIa inhibitors – Do we still need them?
by: Vijayakumar Subban, et al.
Published: (2013-05-01)

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
by: Salam Amar M, et al.
Published: (2001-07-01)

Combined glycoprotein IIb/IIIa inhibitor therapy with ticagrelor for patients with acute coronary syndrome.
by: Zhi-Jiang Xie, et al.
Published: (2021-01-01)

Concomitant Use of Glycoprotein IIb/IIIa Inhibitor and Streptokinase after Unsuccessful Rescue Angioplasty
by: José Marconi Almeida de Sousa, et al.
Published: (2002-04-01)

Pharmacological Profile of a Novel Platelet Glycoprotein IIb/IIIa Antagonist SM-20302
by: Horisawa, Seiya
Published: (2011)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
by: Zhe Wang, et al.
Published: (2020-03-01)

Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.
by: Haiyan Xu, et al.
Published: (2017-01-01)

A systematic review update of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists.
by: Robinson, et al.
Published: (2002-01-01)

Glycoprotein IIb/IIIa and P2Y12 Induction by Oligochitosan Accelerates Platelet Aggregation
by: Mercy Halleluyah Periayah, et al.
Published: (2014-01-01)

Radial Access for Coronary Angiography Carries Fewer Complications Compared with Femoral Access: A Meta-Analysis of Randomized Controlled Trials
by: Gani Bajraktari, et al.
Published: (2021-05-01)

Relationship of Platelet Glycoprotein IIb/IIIa and CD62P With Hypercoagulable State After Oncologic Surgery
by: Xin Zhong, et al.
Published: (2020-11-01)

Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of acute coronary syndrome and in transcutaneous coronary interventions
by: D V Fettser, et al.
Published: (2009-03-01)

EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. I. Makhiyanova, et al.
Published: (2016-01-01)

Markers of endothelial dysfunction in pregnant women with the A2 gene polymorphism of platelet glycoprotein receptors IIb/IIIa
by: A. Y. Muratova, et al.
Published: (2016-02-01)

The action mechanism underlying Staphylococcus aureus-induced platelet aggregation: role of platelet glycoprotein IIb/IIIa complex.
by: Shin-Yi, Huang, et al.

Fluoroscopy time in radial and femoral access angiograms
by: K. Karthikeyan, et al.
Published: (2014-11-01)

Targeted platelet inhibition with a bispecific antibody fragment that binds to platelet glycoprotein IIb/IIIa receptor and tissue factor : prevention of thombosis after angioplasty with a new locally delivered bispecific antibody against tissue factor and platelet glycoprotein IIb/IIIa receptor
by: Hogrefe, Kai
Published: (2005)

Case-control study of platelet glycoprotein receptor Ib and IIb/IIIa expression in patients with acute and chronic cerebrovascular disease.
by: Peter Kraft, et al.
Published: (2015-01-01)

Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction
by: J. P. Howard, et al.
Published: (2014-01-01)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020-01-01)

Intracoronary Glycoprotein IIb/IIIa Inhibitors Improve Short-Term Mortality and Reinfarction in East Asian Patients with ST-Segment Elevation Myocardial Infarction after Thrombus Aspiration: A Meta-Analysis
by: Jia-hong Wu, et al.
Published: (2018-01-01)

Coronary angiography safety between radial and femoral access
by: Osama Tayeh, et al.
Published: (2014-06-01)

Receptor GP IIb/IIIa as an Indicator of Risk in Vascular Events
by: Żanna Fiodorenko-Dumas PhD, et al.
Published: (2019-06-01)

Platelet function in patients with polymorphisms of GP IIb/IIIa and cyclooxygenase
by: McCaslin, James
Published: (2005)

Effects of two different glycoprotein platelet IIb/IIIa inhibitors and the clinical endpoints in patients with intracranial Pipeline flow diverter implant
by: Qiao Deng, et al.
Published: (2020-12-01)

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina.
by: McDonagh, et al.
Published: (2000-01-01)

Radial access versus femoral access in myocardial infarction – a single-center experience
by: Vojko Kanič, et al.
Published: (2019-10-01)

Comparison between femoral access versus radial access in primary percutaneous coronary interventions
by: Ahmed K A. G. Hassan
Published: (2021-01-01)

Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos. The IIb/IIIa platelet receptor inhibitors in the acute coronary syndromes.
by: Fidel Manuel Cáceres Lóriga, et al.
Published: (2001-01-01)

Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use
by: Davide Capodanno, et al.
Published: (2019-12-01)

Flow cytometric observations in quantitative and qualitative platlet disorders and in humans recieving infusions of a chimaeric monoclonal antibody to glycoprotein IIb-IIIa
by: Christopoulos, Constantinos
Published: (1992)

Glycoprotein IIIa Preparation for T-cell Stimulation
by: GR Anani Sarab, et al.
Published: (2005-10-01)

Glycoprotein IIIa Preparation for T-cell Stimulation
by: GR Anani Sarab, et al.
Published: (2005-03-01)

Predictors of Conversion from Radial Into Femoral Access in Cardiac Catheterization
by: Maria Salomé Carvalho, et al.
Published: (2015-05-01)

Safety of radial vs. femoral artery access in coronary angiography
by: C.M.S. Kabir, et al.
Published: (2015-12-01)